Moomoo AI 已提取核心信息
On February 1, 2024, Timothy K Lu, CEO and President of Senti Biosciences, Inc. (SNTI), completed a significant stock transaction involving the company's common stock. Lu was granted 306,000 shares at no cost, as per the transaction details. Following this grant, Lu's direct holdings in Senti Biosciences increased to a total of 865,496 shares. Additionally, Lu has indirect beneficial ownership of 1,056,780 shares, which includes shares held by his spouse and others as detailed in the footnotes. The transaction reflects a substantial increase in Lu's stake in the company, emphasizing his vested interest in the company's success.
On February 1, 2024, Timothy K Lu, CEO and President of Senti Biosciences, Inc. (SNTI), completed a significant stock transaction involving the company's common stock. Lu was granted 306,000 shares at no cost, as per the transaction details. Following this grant, Lu's direct holdings in Senti Biosciences increased to a total of 865,496 shares. Additionally, Lu has indirect beneficial ownership of 1,056,780 shares, which includes shares held by his spouse and others as detailed in the footnotes. The transaction reflects a substantial increase in Lu's stake in the company, emphasizing his vested interest in the company's success.
2024年2月1日，森蒂生物科学公司（SNTI）首席执行官兼总裁卢锦涛完成了一项涉及该公司普通股的重大股票交易。根据交易细节，卢无偿获得了30.6万股股票。在这笔赠款之后，卢在森蒂生物科学的直接持股量增加到总计865,496股。此外，卢拥有1,056,780股股票的间接实益所有权，其中包括其配偶和其他人持有的股份，详见脚注。该交易反映了卢在公司的股份大幅增加，凸显了他在公司成功中的既得利益。
2024年2月1日，森蒂生物科学公司（SNTI）首席执行官兼总裁卢锦涛完成了一项涉及该公司普通股的重大股票交易。根据交易细节，卢无偿获得了30.6万股股票。在这笔赠款之后，卢在森蒂生物科学的直接持股量增加到总计865,496股。此外，卢拥有1,056,780股股票的间接实益所有权，其中包括其配偶和其他人持有的股份，详见脚注。该交易反映了卢在公司的股份大幅增加，凸显了他在公司成功中的既得利益。
有用
没用
该公告为独立文件：